Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra D'Addio

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Haematologica|March 4, 2008
Hematopoietic stem cell mobilizationRoberto M Lemoli, Alessandra D'Addio
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?Roberto M Lemoli, Alessandra D'Addio
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory GroupNicole Blijlevens, Matthias Schwenkglenks, Pamela Bacon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purgingAlessandro Isidori, Maria Rosa Motta, Monica Tani, et al.
British Journal of Haematology|October 4, 2007
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptidesAntonio Curti, Patrizia Tosi, Patrizia Comoli, et al.
Molecular Medicine (Cambridge, Mass.)|April 11, 2026
Multi-parametric profiling of plasma-derived extracellular vesicles reveals a disease-associated molecular signature supporting a liquid biopsy approach in myelofibrosisGhazal Narimanfar, Husam B R Alabed, Alessia Brancolini, et al.
Blood|July 28, 2011
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patientsAntonio Curti, Loredana Ruggeri, Alessandra D'Addio, et al.
Leukemia|May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyureaFrancesca Palandri, Massimo Breccia, Elena M Elli, et al.
Annals of Hematology|August 22, 2025
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian studyAlessandra D'Addio, Michela Rondoni, Marzia Salvucci, et al.
Blood Advances|June 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with RuxolitinibFrancesca Palandri, Alessandra Dedola, Giovanni Caocci, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Haematologica|March 4, 2008
Hematopoietic stem cell mobilizationRoberto M Lemoli, Alessandra D'Addio
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Conditioning regimen using busulfan plus melphalan in hematopoietic stem cell transplantation: can this conditioning regimen be used in autologous or allogeneic transplantation for acute leukemia?Roberto M Lemoli, Alessandra D'Addio
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory GroupNicole Blijlevens, Matthias Schwenkglenks, Pamela Bacon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
Positive selection and transplantation of autologous highly purified CD133(+) stem cells in resistant/relapsed chronic lymphocytic leukemia patients results in rapid hematopoietic reconstitution without an adequate leukemic cell purgingAlessandro Isidori, Maria Rosa Motta, Monica Tani, et al.
British Journal of Haematology|October 4, 2007
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptidesAntonio Curti, Patrizia Tosi, Patrizia Comoli, et al.
Molecular Medicine (Cambridge, Mass.)|April 11, 2026
Multi-parametric profiling of plasma-derived extracellular vesicles reveals a disease-associated molecular signature supporting a liquid biopsy approach in myelofibrosisGhazal Narimanfar, Husam B R Alabed, Alessia Brancolini, et al.
Blood|July 28, 2011
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patientsAntonio Curti, Loredana Ruggeri, Alessandra D'Addio, et al.
Leukemia|May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyureaFrancesca Palandri, Massimo Breccia, Elena M Elli, et al.
Annals of Hematology|August 22, 2025
PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian studyAlessandra D'Addio, Michela Rondoni, Marzia Salvucci, et al.
Blood Advances|June 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with RuxolitinibFrancesca Palandri, Alessandra Dedola, Giovanni Caocci, et al.
Pageof 2